The American Journal of Surgical Pathology · 2006 · 67 citations · 9 references
EngineeringDna AnalysisMolecular BiologyPathologyNucleic Acid Amplification TestBiomedical EngineeringBone Marrow TrephinesRegenerative MedicineBioanalysisHematologyLaboratory MedicineMolecular DiagnosticsRadiologyApplicable Decalcification ProtocolMedical ImagingFluorescent In Situ HybridizationUltrasoundRapid FishBone ImagingNucleic Acid AmplificationDecalcification ProceduresMedicineStandardized Decalcification ProtocolsRt-pcr Analysis
The requisite analyses on bone marrow biopsies are increasing: Molecular analyses such as fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), and reverse transcriptase (RT)-PCR are demanded in addition to morphology and immunohistochemistry to improve diagnostic accuracy. Moreover, analysis of certain molecular prognostic or predictive biomarkers is increasingly mandatory in the assessment of hematologic diseases. In some circumstances, only formalin fixed, bone-containing tissue is available for molecular analysis. Because various fixation and decalcification procedures can impair DNA and RNA quality, there is an urgent need for standardized decalcification protocols which allow FISH and PCR analysis. In this study we developed a routinely applicable decalcification protocol to optimize the molecular analysis method although preserving morphology and immunohistochemical results. Therefore, we compared 2 different approaches including ultrasonic decalcification versus nonultrasonic procedures and ethylenediaminetetraacetate-based reagents versus acid-based ones. In our hands, the combined use of ultrasound and ethylenediaminetetraacetate-based reagents permits successful interphase FISH, PCR, and RT-PCR analysis whereas concomitantly preserving morphology and antigeneicity.
9
Clinical and biologic implications of recurrent genomic aberrations in myeloma
Rafaël Fonseca, Emily Blood, Montserrat Rué et al. · Blood · 2003 · 658 citations
Marcus Kremer, Martin S. Spitzer, Sonja Mandl–Weber et al. · Laboratory Investigation · 2003 · 68 citations
Hematological Malignancy, Lymphoid Neoplasia, Malignant Blood Disorder +7